Organization
Catalyst Global
Carlsbad, CAMission
Part 1: we catalyze access to innovative, high-quality, affordable sexual and reproductive health products and services to facilitate the vibrant health, well-being, and future of girls and women. - Part 3: catalyst global (formerly known as wcg cares) is an international non-profit organization committed to increasing access to innovative, high-quality, affordable sexual and reproductive health products and services to facilitate the vibrant health, well-being, and future of girls and women. Catalyst globals credentials in product introduction have made it a preferred partner of organizations looking to move products from laboratories and manufacturing plants to the women who need them. Catalyst global excels at forming strategic partnerships to introduce and create access to new contraceptive methods around the world. Catalyst globals quality and regulatory departments are experienced in the global registration of drugs and devices, and in aiding manufacturers to improve their processes to meet international best practices. We create options for women when it comes to their reproductive health - no matter where they live.
-
Website: http://WWW.CATALYSTGLOBAL.ORG
-
Phone: 8583144025
-
Principal Officer: SHANNON BLEDSOE
-
EINEIN: 463226871
-
Revenue: $2,918,913
-
Assets: $2,144,515
-
Expenses: $3,147,290
-
Catalyst Global
701 Palomar Airport Rd Ste 300
Carlsbad,
CA
92011
Open Map
All Programs
Catalyst global impact:-catalyst global has increased access to 16 reproductive health products in over 90 countries, including 4 self-care methods.-In partnership with PSI, catalyst global introduced the hormonal iud to over 4,800 women in zambia and madagascar; the caya diaphragm to over 2,400 women in niger and benin; and the womans condom to more than 137,000 women in malawi and zambia.-Catalyst globals regulatory support ensured the continued availability of the manual vacuum aspiration (mva) device for safe surgical abortion to women in 25 countries.-In collaboration with the university of california, san francisco and Harvard university, catalyst global supports one clinical trial for a biotherapeutic gel for HIV prevention.-Catalyst global supports the population councils acceptability study for a multipurpose technology, the dual-prevention pill (contraception and HIV prevention).